搜索临床试验以:Purinergic P1 Receptor Agonists
总计7397个结果
-
GE HealthcareCovance招聘中
-
M.D. Anderson Cancer CenterAstellas Scientific & Medical Affairs, Inc.主动,不招人
-
University of Alabama at BirminghamAstellas Scientific & Medical Affairs, Inc.完全的
-
Christine Lau, MDNational Heart, Lung, and Blood Institute (NHLBI)未知
-
Dana-Farber Cancer InstituteJohns Hopkins University; Washington University School of Medicine; National Heart, Lung, and... 和其他合作者完全的
-
Medical University of South CarolinaAstellas Pharma US, Inc.完全的
-
Timothy M. BatemanSaint Luke's Health System; Saint Luke's Cardiovascular Consultants完全的
-
Washington University School of MedicineAstellas Pharma US, Inc.完全的
-
Dipan ShahAstellas Pharma Global Development, Inc.未知
-
Astellas Pharma Global Development, Inc.完全的
-
University of Maryland, BaltimoreAstellas Pharma US, Inc.完全的
-
Washington University School of MedicineAstellas Pharma US, Inc.完全的
-
Timothy M. Bateman, MD完全的
-
University of Maryland, BaltimoreNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
University of NebraskaMayo Clinic; Astellas Pharma Inc完全的
-
German Heart InstituteGE Healthcare尚未招聘
-
University of NebraskaGE Healthcare; Astellas Pharma US, Inc.完全的
-
Marvin W. Kronenberg, M.D.Astellas Pharma US, Inc.完全的
-
Northwestern UniversityAstellas Pharma Global Development, Inc.完全的
-
Dana-Farber Cancer InstituteJohns Hopkins University; Baylor College of Medicine; Washington University School of Medicine; National... 和其他合作者完全的
-
St. Louis UniversityAstellas Pharma US, Inc.; University of Florida完全的
-
Gilead SciencesAstellas Pharma US, Inc.完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)终止
-
Astellas Pharma Global Development, Inc.完全的使用单光子发射计算机断层扫描 (SPECT) 进行心肌灌注成像 (MPI) 与单独使用 Regadenoson 相比,在不充分的运动压力测试后评估 Regadenoson 给药的研究 (EXERRT)冠状动脉疾病 (CAD)美国, 秘鲁, 阿根廷, 波多黎各